April 12, 2026 04:20 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Legendary singer Asha Bhosle suffers cardiac arrest, hospitalised | Big boost to India–Mauritius ties: S. Jaishankar hands over 90 e-buses | Middle East tension: Iranian delegation arrives in Islamabad for major talks, 10,000 security personnel deployed | Ranveer Singh visits RSS HQ amid Dhurandhar 2 success, triggers speculation | ED raids ex-Bengal minister Partha Chatterjee; SSC scam resurfaces ahead of polls | Amit Shah promises UCC, ₹3,000 aid per month for women and youth in BJP’s Bengal manifesto | Nitish Kumar takes Rajya Sabha oath; power shift looms in Bihar | Sting video fallout: AIMIM snaps electoral ties with Humayun Kabir in Bengal | Israel says Hezbollah chief’s nephew-cum-secretary killed in Beirut strikes last night | Modi slams TMC on trade, fisheries at Haldia; vows 7th pay commission for govt employees
India-Canada
Image Credit: Covishield Twitter handle

India commits to ship Covishield vaccines to Canada within a month

| @indiablooms | Feb 16, 2021, at 04:46 am

Canada/IBNS: Adar Poonawalla, the chief executive of Serum Institute of India (SII), confirmed on Monday that Covishield vaccines would be shipped to Canada within a month.

"As we await regulatory approvals from Canada, I assure you, @SerumInstIndia will fly out #COVISHIELD to Canada in less than a month; I'm on it!" Poonawalla said in a tweet, using the brand name under which Serum produces the shot developed by Oxford University and AstraZeneca Plc.

Earlier, Canada's Prime Minister Justin Trudeau had also been assured by India's Prime Minister Narendra Modi during their discussion on Monday, that India would do its best to supply COVID-19 vaccines sought by Canada.

"Minister Anand continues to make every effort to ensure that vaccines are delivered to Canada as early as possible from a diverse range of suppliers. We will announce details of any agreement once it is finalized," said James Fitz-Morris in an email.

Approval of two separate applications for a vaccine developed by AstraZeneca and Oxford University researchers, including a joint pitch from SII, a private enterprise in Pune in western India, is being reviewed by Health Canada.

Canada has a deal with AstraZeneca for 20 million doses.

(Reporting by Asha Bajaj)
 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.